A novel compound having agonist activity at the S.sub.1P.sub.3 receptor which is represented by the formula I ##STR00001## wherein X is selected from the group consisting of CR.sup.3, N and NO; Y is selected from the group consisting of CR.sup.3, N and NO; Z is selected from the group consisting of CR.sup.3, N and NO; and at least one of X, Y and Z is N or NO; V is O or NOR.sup.4 R.sup.1 is an aryl group; R.sup.2 is an aryl group; R.sup.3 is selected from the group consisting of H and alkyl; and 2 of said R.sup.3 groups may together form a cyclic alkyl ring having from 3 to 6 carbon atoms; R.sup.4 is selected from the group consisting of H and alkyl; a is 0 or an integer of from 1 to 6; b is 0 or 1; c is 0 or 1; f is 0 or an integer of 1 or 2; x is 0 or 1; y is 0 or an integer of from 1 to 3; and z is 0 or an integer of from 1 to 3.

 
Web www.patentalert.com

< Use of pyrrolopyridine compounds for activating PPAR receptors and treatment of conditions involving such receptors

< N-linked heterocyclic antagonists of P2Y.sub.1 receptor useful in the treatment of thrombotic conditions

> Phenoxymethylalkyne inhibitors of LTA4H for treating inflammation

> Treating neurological disorders using selective antagonists of persistent sodium current

~ 00611